Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI World Health Care Advanced Select 20 35 Capped |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | GBP 264 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 14.06% |
| Inception/ Listing Date | 3 November 2021 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 30 November |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | Unknown |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Eli Lilly & Co | 10.33% |
| AbbVie | 4.84% |
| Novartis | 4.68% |
| Johnson & Johnson | 4.57% |
| AstraZeneca | 3.89% |
| UnitedHealth Group | 3.31% |
| Gilead Sciences | 2.68% |
| Merck & Co | 2.67% |
| Roche Holding | 2.53% |
| Novo Nordisk | 2.13% |
| United States | 66.75% |
| Switzerland | 10.94% |
| United Kingdom | 5.01% |
| Japan | 4.05% |
| Other | 13.25% |
| Health Care | 94.45% |
| Consumer Discretionary | 1.07% |
| Consumer Staples | 0.23% |
| Other | 4.25% |
| YTD | +1.44% |
| 1 month | -0.71% |
| 3 months | -2.09% |
| 6 months | +13.75% |
| 1 year | +3.18% |
| 3 years | +6.57% |
| 5 years | - |
| Since inception (MAX) | +15.62% |
| 2025 | +6.94% |
| 2024 | -3.71% |
| 2023 | -1.70% |
| 2022 | +8.16% |
| Volatility 1 year | 14.06% |
| Volatility 3 years | 12.85% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.23 |
| Return per risk 3 years | 0.17 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -14.15% |
| Maximum drawdown 3 years | -19.45% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -19.45% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | CBUR | - - | - - | - |
| Euronext Amsterdam | EUR | WHCA | WHCA NA | ||
| London Stock Exchange | GBP | WHCA | |||
| SIX Swiss Exchange | USD | WHCA |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 908 | 0.40% p.a. | Accumulating | Sampling |
| iShares Ageing Population UCITS ETF | 583 | 0.40% p.a. | Accumulating | Sampling |
| Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 23 | 0.35% p.a. | Accumulating | Full replication |
| Invesco S&P World Health Care ESG UCITS ETF Acc | 14 | 0.18% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 12 | 0.35% p.a. | Accumulating | Full replication |